China Pharma Holdings, Inc. (CPHI): Price and Financial Metrics

China Pharma Holdings, Inc. (CPHI): $0.10

0.00 (-3.22%)

POWR Rating

Component Grades













Add CPHI to Watchlist
Sign Up

Industry: China



in industry

CPHI Stock Summary

  • CPHI has a market capitalization of $5,422,466 -- more than approximately just 1.35% of US stocks.
  • Of note is the ratio of CHINA PHARMA HOLDINGS INC's sales and general administrative expense to its total operating expenses; 98.08% of US stocks have a lower such ratio.
  • CHINA PHARMA HOLDINGS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -64.95%, greater than the shareholder yield of only 8.53% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CHINA PHARMA HOLDINGS INC are ICL, FMS, YAYO, SPB, and FSM.
  • Visit CPHI's SEC page to see the company's official filings. To visit the company's web site, go to

CPHI Valuation Summary

  • In comparison to the median Healthcare stock, CPHI's price/sales ratio is 85.42% lower, now standing at 0.7.
  • Over the past 169 months, CPHI's EV/EBIT ratio has gone down 6.6.

Below are key valuation metrics over time for CPHI.

Stock Date P/S P/B P/E EV/EBIT
CPHI 2022-11-25 0.7 1.9 -1.5 -4.4
CPHI 2022-11-23 0.7 1.9 -1.5 -4.4
CPHI 2022-11-22 0.7 1.9 -1.4 -4.4
CPHI 2022-11-21 0.6 1.7 -1.3 -4.3
CPHI 2022-11-18 0.7 1.9 -1.5 -4.5
CPHI 2022-11-17 0.7 2.1 -1.6 -4.6

CPHI Growth Metrics

    Its 2 year revenue growth rate is now at -8.93%.
  • The 3 year price growth rate now stands at -35.31%.
  • The 4 year net cashflow from operations growth rate now stands at -90.55%.
CPHI's revenue has moved down $2,851,476 over the prior 33 months.

The table below shows CPHI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 8.07246 -1.192251 -3.689376
2022-06-30 8.085156 -1.86222 -3.725272
2022-03-31 8.887559 -0.852361 -3.661639
2021-12-31 9.641925 -0.249838 -3.399476
2021-09-30 9.683661 0.283142 -3.627794
2021-06-30 10.1057 0.5096 -3.811021

CPHI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CPHI has a Quality Grade of C, ranking ahead of 56.06% of graded US stocks.
  • CPHI's asset turnover comes in at 0.493 -- ranking 88th of 677 Pharmaceutical Products stocks.
  • DRNA, ONVO, and CASI are the stocks whose asset turnover ratios are most correlated with CPHI.

The table below shows CPHI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.493 0.094 -0.236
2021-03-31 0.538 0.177 -0.174
2020-12-31 0.495 0.180 -0.168
2020-09-30 0.494 0.153 -1.332
2020-06-30 0.407 0.183 -0.990
2020-03-31 0.306 0.105 -0.802

CPHI Stock Price Chart Interactive Chart >

Price chart for CPHI

CPHI Price/Volume Stats

Current price $0.10 52-week high $0.67
Prev. close $0.11 52-week low $0.09
Day low $0.10 Volume 62,036
Day high $0.11 Avg. volume 226,931
50-day MA $0.13 Dividend yield N/A
200-day MA $0.24 Market Cap 5.27M

CPHI Latest News Stream

Event/Time News Detail
Loading, please wait...

CPHI Latest Social Stream

Loading social stream, please wait...

View Full CPHI Social Stream

Latest CPHI News From Around the Web

Below are the latest news stories about CHINA PHARMA HOLDINGS INC that investors may wish to consider to help them evaluate CPHI as an investment opportunity.

Do investors need to be concerned about China Pharma Holdings Inc. (CPHI)?

A share of China Pharma Holdings Inc. (AMEX:CPHI) closed at $0.15 per share on Wednesday, up from $0.13 day before. While China Pharma Holdings Inc. has overperformed by 20.16%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CPHI fell by -72.53%, with highs and lows ranging […]

US Post News | October 20, 2022

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

China Pharma Holdings, Inc. (NYSE American: CPHI; the "Company") today announced that on September 26, 2022, the Company received notification (the "Deficiency Letter") from the NYSE AMERICAN LLC ("NYSE American") informing it that the Company is not in compliance with certain NYSE American continued listing standards (the "Listing Standards"). The Deficiency Letter indicated that the Company's securities had been selling for a low price per share for a substantial period of time and, most recen

Yahoo | October 2, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.

William White on InvestorPlace | September 22, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares!

William White on InvestorPlace | September 21, 2022

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on July 15, 2022, the Company submitted a plan of compliance to NYSE American LLC ("NYSE American" or the "Exchange") to address the deficiency in the Company's stockholders' equity as pointed out in the letter from the Exchange dated June 15, 2022 (the "Letter").

Yahoo | July 18, 2022

Read More 'CPHI' Stories Here

CPHI Price Returns

1-mo -23.66%
3-mo -47.70%
6-mo -60.78%
1-year -81.48%
3-year -56.73%
5-year -44.44%
YTD -79.28%
2021 8.25%
2020 88.26%
2019 -7.86%
2018 42.78%
2017 -30.77%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8375 seconds.